Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serine protease 1 | 0.563 | 0.692 | 4.1E-11 |
|
phenotype | 0.020 | None | < 0.001 | 2 | 1 | 2001 | 2017 | ||||||||
|
BCL2 interacting protein 3 | 0.520 | 0.731 | 2.0E-05 |
|
phenotype | 0.020 | None | < 0.001 | 2 | 0 | 2007 | 2008 | ||||||||
|
microRNA 450b | 0.769 | 0.269 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 3658 | 0.890 | 0.115 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 378g | 1.000 | 0.115 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | |||||||||
|
Down syndrome critical region 4 | 0.890 | 0.115 | 7.8E-04 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 | 0.576 | 0.654 | 0.76 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
kelch domain containing 7B | 0.861 | 0.154 | 1.2E-09 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
creatine kinase B | 0.608 | 0.615 | 0.22 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
tripartite motif containing 71 | 0.861 | 0.192 | 1.00 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
mucin 17, cell surface associated | 0.638 | 0.577 | 7.9E-63 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
cystatin B | 0.530 | 0.692 | 6.6E-03 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
developmental pluripotency associated 2 | 0.839 | 0.192 | 4.8E-09 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
ferritin heavy chain 1 | 0.559 | 0.731 | 0.14 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
glucosaminyl (N-acetyl) transferase 1 | 0.716 | 0.346 | 3.3E-03 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
homeobox C5 | 0.682 | 0.269 | 5.8E-05 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
interferon alpha and beta receptor subunit 2 | 0.585 | 0.731 | 8.5E-06 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
LDL receptor related protein associated protein 1 | 0.579 | 0.731 | 4.5E-07 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 1986 | 1986 | ||||||||
|
MAX network transcriptional repressor | 0.663 | 0.615 | 1.00 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 | 0.554 | 0.769 | 4.5E-03 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
mucin 3A, cell surface associated | 0.636 | 0.500 | 1.5E-10 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
myosin binding protein C3 | 0.593 | 0.385 | 8.0E-11 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 |